Fabry's disease epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Ghsanadgol (talk | contribs) |
Jose Loyola (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Fabry's disease}} | {{Fabry's disease}} | ||
Revision as of 19:54, 25 April 2022
|
Fabry's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fabry's disease epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Fabry's disease epidemiology and demographics |
|
Risk calculators and risk factors for Fabry's disease epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Fabry's disease is a rare condition mainly underestimated due to its rarity and some nonspecific symptoms. This disease mostly affects men and has no rational disparities.
Epidemiology and Demographics[1]
Prevalence
- In 2021, the prevalence of Fabry's disease was estimated to be approximately 1:17,000 to 1:117,000 in men.
- The prevalence of Classic phenotype is estimated approximately 1:22,000 to 1:40,000 in men.
- The prevalence of atypical phenotype is about 1:1000 to 1:3000 in men and 1:6000 to 1:40,000 in females.
Incidence
- Incidence of Fabry's disease is commonly underestimated.
Gender
- Men are more commonly affected with Fabry's disease than females. The male to female ratio is approximately 2 to 1.
Race
- The prevalence of Fabry's disease does not vary by race.
References